2 August 2018 - Deborah Wilkes
Archived
Worldwide sales at Pfizer's Consumer Healthcare business increased by 2% on an operational basis to USD886 million in the second quarter of 2018. Pfizer continues to evaluate strategic alternatives for its Consumer Healthcare business including spin-offs and joint ventures.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.